Quantel Medical®: Innovating Healthcare with Vitality and Excellence
At the heart of the medical technology revolution is Quantel Medical®, a brand synonymous with cutting-edge innovation, vitality, and excellence.
Founded in 1993 as a subsidiary of the Quantel Group, Quantel Medical® has become a key player in the field of ophthalmology, transforming lives through revolutionary laser and ultrasound technologies.
From diagnosis to treatment of the four main causes of blindness – cataract, glaucoma, diabetic retinopathy and macular degeneration as well as other pathologies such as dry eye, Quantel Medical® continues to push the boundaries of medical excellence.
Vitality and Excellence are the pillars that define Quantel Medical®. These core values drive every aspect of the company’s operations—from product development to customer relationships.
Vitality represents the relentless energy and passion with which the team approaches innovation, continuously striving to exceed the expectations of healthcare professionals worldwide.
Excellence, on the other hand, is reflected in the uncompromising quality and reliability of the technologies developed by Quantel Medical®. The company has earned a reputation for delivering high-performance solutions that have become essential tools in medical practices globally.
This perfect balance of vitality and excellence ensures that Quantel Medical® remains at the forefront of medical technology innovation, delivering life-changing solutions to millions of patients.
Quantel Medical®’s success is built on its robust global presence, with a vast network of trusted distributors representing the brand in over 110 countries. These distributors play a key role in the company’s worldwide expansion by providing local expertise and fostering close relationships with healthcare professionals. By collaborating with partners who understand the specific needs of their regions, Quantel Medical® ensures that its solutions are tailored to local markets while maintaining the highest international standards. This global reach, combined with a deep respect for cultural and regional differences, allows Quantel Medical® to thrive on the world stage, offering cutting-edge solutions across diverse environments.
Quantel Medical® is more than just a manufacturer of medical devices—it is a brand that constantly challenges conventions and redefines what’s possible. By adopting a dynamic and creative approach, the company is able to offer solutions that address the evolving needs of the healthcare community. This boldness in thinking and refusal to conform to industry norms allow Quantel Medical® to push the limits of medical technology, providing cutting-edge tools that inspire new ways of treating patients.
Whether enhancing diagnostic precision or developing breakthrough treatments for eye diseases, Quantel Medical® anticipates future challenges and actively seeks innovative approaches to meet them. This unconventional and creative spirit, combined with a strong foundation in technological excellence, has helped the company carve out a unique position in the medical landscape—always a step ahead of the curve, yet never losing sight of the practical needs of clinicians and patients.
World Leader in Ophthalmic Ultrasound
Quantel Medical® stands as a global leader in ophthalmic ultrasound, a position achieved through years of pioneering advancements. Since 1993, the company has developed a comprehensive range of ultrasound systems that are trusted by ophthalmologists worldwide for their precision and reliability in diagnosis and treatment planning. Early innovations include the analog B-scan for cataract surgery in 1993 and the Cinescan in 1998, which introduced video recording capabilities. A major breakthrough came in 2003 with the development of high-frequency probes for detailed retina and anterior chamber imaging.
In 2005, Quantel Medical® revolutionized the field with the Aviso®, the first modular digital ultrasound platform, offering unmatched flexibility and enhanced diagnostic capabilities. The introduction of the Lin25 and Lin50 probes for UBM further cemented its leadership. More recent innovations, such as the Compact Touch® and ABSolu®, continue to demonstrate Quantel Medical®’s commitment to providing advanced, future-oriented solutions that continuously improve patient care.
Since 2018, Lumibird Medical has extended its expertise to other medical specialties by offering a range of interventional imaging products that meet the needs of general practitioners, emergency, sport medicine, anesthesia/intensive care and much more… Interventional imaging uses imaging to perform a precise and less invasive diagnostic and therapeutic procedure than surgery. This technique results in less pain for the patient, less risk of infection, and shorter hospitalization and convalescence periods.
A Legacy of Retina Laser Innovation
Quantel Medical® is renowned for its expertise in retina laser technology, having introduced several groundbreaking products that have transformed the field of ophthalmology:
- Viridis solid-state photocoagulator: Launched in 1995, this laser marked a pivotal shift away from argon lasers, offering enhanced precision and efficiency in retina treatments.
- Vitra 532nm photocoagulator: Known for its compact size and high performance, this laser quickly became a preferred tool for retina specialists.
- Supra Scan 577: Introduced in 2009, this multispot laser with SubLiminal technology set a new standard for treating retinal pathologies, allowing for faster and more precise procedures with less collateral damage.
- Easyret®: Following the Supra Scan® 577, the Easyret® represents the next generation of retina lasers, featuring advanced scanning patterns and SubLiminal technology. This laser offers versatility and precision in treating various retinal diseases, ensuring minimal tissue damage and faster recovery times for patients.
Each of these innovations reflects Quantel Medical®’s commitment to providing healthcare professionals with the tools they need to deliver better patient outcomes.
Anterior Segment and Glaucoma Lasers
In addition to its retina lasers, Quantel Medical® has made significant advancements in anterior segment and glaucoma treatments. Notable products include:
- Solutis SLT laser: Introduced in 2007, this was the first affordable selective laser trabeculoplasty (SLT) laser, making glaucoma treatments more accessible to patients worldwide.
- Optimis Fusion™ YAG/SLT laser: Launched in 2014, this laser combines both YAG and SLT functionalities in one device, providing ophthalmologists with a versatile tool for treating cataracts and glaucoma.
- Vitra 810™ laser: This laser is an 810 nm infrared laser used in ophthalmology for treating glaucoma and retinal diseases. It features modes like thermal and sub-threshold cyclophotocoagulation (SubCyclo) and retinal photocoagulation.
- Capsulo® YAG laser: Introduced in 2022, this laser further advances the treatment of anterior segment conditions by offering enhanced precision and ease of use.
Innovating in Dry Eye Diagnosis and Treatment
In 2018, Quantel Medical® expanded its expertise into the rapidly growing field of dry eye disease, understanding the evolving needs of healthcare professionals and the increasing prevalence of this condition. After four years of gathering insights from the market, the company launched its own complete range of diagnostic and treatment solutions. In 2022, Quantel Medical® introduced the IPL C.STIM®, an innovative Intense Pulsed Light (IPL) system for treating dry eye. This was followed in 2024 by the release of C.DIAG®, the most advanced automatic diagnostic platform dedicated to dry eye and ocular surface diseases.
In addition to developing cutting-edge devices, Quantel Medical® has also committed to supporting patients through educational content, helping those affected by dry eye understand their condition and adopt effective lifestyle advice.
The Future: Unstoppable Progress
As Quantel Medical® moves forward, its focus remains on continuous innovation and improving lives through technology. With its heritage of pioneering products and a commitment to creativity and excellence, the company is poised to continue shaping the future of medical technology.
The merger of Quantel Medical® with Ellex and Optotek Medical, forming the Lumibird Medical Group, has only strengthened its position in the industry, enabling Quantel Medical® to extend its reach and offer even more advanced solutions in ophthalmology and beyond.
Quantel Medical®’s unwavering commitment to innovation ensures that it will remain a key player in the global medical technology market for years to come, improving patient outcomes and redefining the future of healthcare.